Methylthioninium chloride Proveblue الاتحاد الأوروبي - اللاتفية - EMA (European Medicines Agency)

methylthioninium chloride proveblue

provepharm sas - methylthioninium chloride - methemoglobīnēmija - visi pārējie terapeitiskie produkti - medicīnisko un ķīmisko produktu izraisīta methemoglobinēmija akūta simptomātiska ārstēšana. methylthioninium hlorīds proveblue ir norādīts pieaugušajiem, bērniem un pusaudžiem (vecumā no 0 līdz 17 gadiem).

Lumeblue (previously known as Methylthioninium chloride Cosmo) الاتحاد الأوروبي - اللاتفية - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - methylthioninium chloride - colorectal neoplasms; colonoscopy - citi diagnostiskie līdzekļi - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Sitagliptin / Metformin hydrochloride Accord الاتحاد الأوروبي - اللاتفية - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , triple kombinēto terapiju), kā palīglīdzekli, lai diētu un vingrošanu pacientiem nepietiekami kontrolē par to maksimālā pieļaujama devu metformīns un sulfonilurīnvielas pamata. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Sitagliptin / Metformin hydrochloride Sun الاتحاد الأوروبي - اللاتفية - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , triple kombinēto terapiju), kā palīglīdzekli, lai diētu un vingrošanu pacientiem nepietiekami kontrolē par to maksimālā pieļaujama devu metformīns un sulfonilurīnvielas pamata. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Hydroxychloroquine sulfate Accord 200 mg apvalkotās tabletes لاتفيا - اللاتفية - Zāļu valsts aģentūra

hydroxychloroquine sulfate accord 200 mg apvalkotās tabletes

accord healthcare b.v., netherlands - hidroksihlorohīna sulfāts - apvalkotā tablete - 200 mg

Amlodipine/Valsartan/Hydrochlorothiazide Teva 10mg/160mg/12,5 mg apvalkotās tabletes لاتفيا - اللاتفية - Zāļu valsts aģentūra

amlodipine/valsartan/hydrochlorothiazide teva 10mg/160mg/12,5 mg apvalkotās tabletes

teva b.v., netherlands - amlodipinum, valsartanum, hydrochlorothiazidum - apvalkotā tablete - 10 mg/160 mg/12,5 mg

Potassium Chloride/Glucose Fresenius 1,5 mg/50 mg/ml šķīdums infūzijām لاتفيا - اللاتفية - Zāļu valsts aģentūra

potassium chloride/glucose fresenius 1,5 mg/50 mg/ml šķīdums infūzijām

fresenius kabi deutschland gmbh, germany - kalii chloridum, glikozes - Šķīdums infūzijām - 1,5 mg/50 mg/ml

Potassium Chloride/Glucose Fresenius 3 mg/50 mg/ml šķīdums infūzijām لاتفيا - اللاتفية - Zāļu valsts aģentūra

potassium chloride/glucose fresenius 3 mg/50 mg/ml šķīdums infūzijām

fresenius kabi deutschland gmbh, germany - kalii chloridum, glikozes - Šķīdums infūzijām - 3 mg/50 mg/ml

Candesartan cilexetil/Hydrochlorothiazide Teva 16 mg/12,5 mg tabletes لاتفيا - اللاتفية - Zāļu valsts aģentūra

candesartan cilexetil/hydrochlorothiazide teva 16 mg/12,5 mg tabletes

teva pharma b.v., netherlands - candesartanum cilexetilum, hydrochlorothiazidum - tablete - 16 mg/12,5 mg

Potassium Chloride/Sodium Chloride Fresenius 1,5 mg/9 mg/ml šķīdums infūzijām لاتفيا - اللاتفية - Zāļu valsts aģentūra

potassium chloride/sodium chloride fresenius 1,5 mg/9 mg/ml šķīdums infūzijām

fresenius kabi deutschland gmbh, germany - kalii chloridum, natrii chloridum - Šķīdums infūzijām - 1,5 mg/9 mg/ml